Sol-Gel Technologies Ltd

NASDAQ:SLGL   3:15:48 PM EDT
7.47
+0.14 (+1.84%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)21.18M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.2 Million
Adjusted EPS-$1.20
See more estimates
10-Day MA$7.37
50-Day MA$7.39
200-Day MA$6.82
See more pivots

Sol-Gel Technologies Ltd Stock, NASDAQ:SLGL

Weizmann Science Park, 7 Golda Meir Street, Ness Ziona, Tel Aviv 74036
Israel
Phone: +972.8.931.3433
Number of Employees: 36

Description

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.